Network based analysis of hepatitis C virus core and NS4B protein interactions.

Hepatitis C virus (HCV) is a major cause of chronic liver disease worldwide. Here we attempt to further our understanding of the biological context of protein interactions in HCV pathogenesis, by investigating interactions between HCV proteins Core and NS4B and human host proteins. Using the yeast two-hybrid (Y2H) membrane protein system, eleven human host proteins interacting with Core and 45 interacting with NS4B were identified, most of which are novel. These interactions were used to infer overall protein interaction maps linking the viral proteins with components of the host cellular networks. Core and NS4B proteins contribute to highly compact interaction networks that may enable the virus to respond rapidly to host physiological responses to HCV infection. Analysis of the interaction networks highlighted enriched biological pathways likely influenced in HCV infection. Inspection of individual interactions offered further insights into the possible mechanisms that permit HCV to evade the host immune response and appropriate host metabolic machinery. Follow-up cellular assays with cell lines infected with HCV genotype 1b and 2a strains validated Core interacting proteins ENO1 and SLC25A5 and host protein PXN as novel regulators of HCV replication and viral production. ENO1 siRNA knockdown was found to inhibit HCV replication in both the HCV genotypes and viral RNA release in genotype 2a. PXN siRNA inhibition was observed to inhibit replication specifically in genotype 1b but not in genotype 2a, while SLC25A5 siRNA facilitated a minor increase in the viral RNA release in genotype 2a. Thus, our analysis can provide potential targets for more effective anti-HCV therapeutic intervention.

[1]  A. Burroughs,et al.  Coagulation and fibrosis in chronic liver disease , 2008, Gut.

[2]  B. Berger,et al.  Herpesviral Protein Networks and Their Interaction with the Human Proteome , 2006, Science.

[3]  H. Grisé,et al.  Cellular and molecular biology of HCV infection and hepatitis. , 2009, Clinical science.

[4]  William Stafford Noble,et al.  How does multiple testing correction work? , 2009, Nature Biotechnology.

[5]  Mary Ann Comunale,et al.  Novel Fucosylated Biomarkers for the Early Detection of Hepatocellular Carcinoma , 2009, Cancer Epidemiology Biomarkers & Prevention.

[6]  Darius Moradpour,et al.  Replication of hepatitis C virus , 2007, Nature Reviews Microbiology.

[7]  E. de Villiers,et al.  Degradation of HPV20E6 by p53: ΔNp63α and mutant p53R248W protect the wild type p53 mediated caspase‐degradation , 2008, International journal of cancer.

[8]  M. Moon,et al.  Elevated hepatic iron: a confounding factor in chronic hepatitis C. , 2009, Biochimica et biophysica acta.

[9]  S. Dandekar,et al.  Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes. , 2006, Virology.

[10]  R. Francesco,et al.  Challenges and successes in developing new therapies for hepatitis C , 2005, Nature.

[11]  R. Bartenschlager,et al.  Targeting of Hepatitis C Virus Core Protein to Mitochondria through a Novel C-Terminal Localization Motif , 2004, Journal of Virology.

[12]  Hyo Jin Kang,et al.  Structure of human alpha-enolase (hENO1), a multifunctional glycolytic enzyme. , 2008, Acta crystallographica. Section D, Biological crystallography.

[13]  A. Molla,et al.  Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology , 2007, Hepatology.

[14]  A. Dlasková,et al.  Oxidative stress caused by blocking of mitochondrial complex I H(+) pumping as a link in aging/disease vicious cycle. , 2008, The international journal of biochemistry & cell biology.

[15]  S. Okada,et al.  Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment. , 2010, Biochemical and biophysical research communications.

[16]  R. Simó,et al.  Glucose abnormalities in non‐alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload , 2009, Diabetes/metabolism research and reviews.

[17]  H. Hase,et al.  NEMO/IKKγ regulates an early NF-κB-independent cell death checkpoint during TNF signaling , 2009, Cell Death and Differentiation.

[18]  Matthew D. Dyer,et al.  The Landscape of Human Proteins Interacting with Viruses and Other Pathogens , 2008, PLoS pathogens.

[19]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[20]  P. Donaldson,et al.  Apolipoprotein B‐associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti‐viral agents interferon‐alpha and ribavirin , 2009, Alimentary pharmacology & therapeutics.

[21]  S. Lemon,et al.  Role of Hepatitis C virus core protein in viral‐induced mitochondrial dysfunction , 2010, Journal of viral hepatitis.

[22]  P. Desmond,et al.  Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver , 2011, Journal of viral hepatitis.

[23]  P. Boya,et al.  Nuclear factor‐κB in the liver of patients with chronic hepatitis C: Decreased RelA expression is associated with enhanced fibrosis progression , 2001, Hepatology.

[24]  Keiji Tanaka,et al.  Involvement of the PA28γ-Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein , 2006, Journal of Virology.

[25]  Shyi-Jang Shin,et al.  Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C. , 2009, Journal of hepatology.

[26]  B. Bartosch Hepatitis C virus and its complex interplay with hepatic glucose and lipid metabolism. , 2009, Journal of hepatology.

[27]  A. Das,et al.  Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1 , 2010, Journal of gastroenterology and hepatology.

[28]  Darius Moradpour,et al.  Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory , 2010, Reviews in medical virology.

[29]  M. Mizokami,et al.  Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. , 2003, Gastroenterology.

[30]  M. Katze,et al.  Systems biology and the host response to viral infection , 2007, Nature Biotechnology.

[31]  Kyu-Jin Park,et al.  Nonstructural 5A Protein of Hepatitis C Virus Modulates Tumor Necrosis Factor α-stimulated Nuclear Factor κB Activation* , 2002, The Journal of Biological Chemistry.

[32]  Nathan H. Roy,et al.  Tetraspanins regulate cell-to-cell transmission of HIV-1 , 2009, Retrovirology.

[33]  Y. Matsuura,et al.  Involvement of PA28γ in the propagation of hepatitis C virus , 2010, Hepatology.

[34]  B. Kee,et al.  Extrinsic and intrinsic regulation of early natural killer cell development , 2008, Immunologic research.

[35]  Y. Matsuura,et al.  Hepatitis C virus core protein: its coordinate roles with PA28gamma in metabolic abnormality and carcinogenicity in the liver. , 2008, The international journal of biochemistry & cell biology.

[36]  S. Zeuzem Interferon-based therapy for chronic hepatitis C: current and future perspectives , 2008, Nature Clinical Practice Gastroenterology &Hepatology.

[37]  Thomas Lengauer,et al.  Structural and functional comparison of the non-structural protein 4B in flaviviridae. , 2007, Journal of molecular graphics & modelling.

[38]  M. Vidal,et al.  Hepatitis C virus infection protein network , 2008, Molecular systems biology.

[39]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[40]  M. Gale,et al.  Regulation of innate immunity against hepatitis C virus infection , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[41]  N. Garg,et al.  Oxidative modification of mitochondrial respiratory complexes in response to the stress of Trypanosoma cruzi infection. , 2004, Free radical biology & medicine.

[42]  Z. Ling,et al.  Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma. , 2009, World journal of gastroenterology.

[43]  E. Ulvestad,et al.  The hepatitis C virus enigma , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[44]  A. Vazquez,et al.  Epstein–Barr virus and virus human protein interaction maps , 2007, Proceedings of the National Academy of Sciences.

[45]  J. Dubuisson Hepatitis C virus proteins. , 2007, World journal of gastroenterology.

[46]  T. Berg,et al.  Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies. , 2010, Trends in molecular medicine.

[47]  J. Dou,et al.  Characterization of the cellular immune response in hepatitis C virus infection , 2009, Medicinal research reviews.

[48]  N. Kato,et al.  Efficient replication systems for hepatitis C virus using a new human hepatoma cell line. , 2009, Virus research.

[49]  B. Chabi,et al.  ANT2 Isoform Required for Cancer Cell Glycolysis , 2005, Journal of bioenergetics and biomembranes.

[50]  Takayoshi Ito,et al.  Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence , 2008, Journal of gastroenterology and hepatology.

[51]  J. Kapitulnik,et al.  Complement activation and disease: protective effects of hyperbilirubinaemia. , 2009, Clinical science.

[52]  Kiyoko F. Aoki-Kinoshita,et al.  Gene annotation and pathway mapping in KEGG. , 2007, Methods in molecular biology.

[53]  R. Bartenschlager,et al.  Persistent and Transient Replication of Full-Length Hepatitis C Virus Genomes in Cell Culture , 2002, Journal of Virology.

[54]  Michael L. Creech,et al.  Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.

[55]  T. Alempijevic,et al.  Upsala Journal of Medical Sciences. 2009; 114: 228–234 ORIGINAL ARTICLE Alpha-1-antitrypsin phenotypes in adult liver disease patients , 2022 .

[56]  S. Weinman,et al.  Hepatitis C Virus Core Protein Inhibits Mitochondrial Electron Transport and Increases Reactive Oxygen Species (ROS) Production* , 2005, Journal of Biological Chemistry.

[57]  K. DeMali,et al.  Vinculin regulates cell-surface E-cadherin expression by binding to β-catenin , 2010, Journal of Cell Science.

[58]  R. D. de Man,et al.  Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review. , 2007, The Netherlands journal of medicine.

[59]  A. Siddiqui,et al.  Hepatitis C virus hijacks host lipid metabolism , 2010, Trends in Endocrinology & Metabolism.

[60]  Shizuo Akira,et al.  Toll‐like Receptor and RIG‐1‐like Receptor Signaling , 2008, Annals of the New York Academy of Sciences.

[61]  R. Singaravelu,et al.  Activity-based protein profiling of the hepatitis C virus replication in Huh-7 hepatoma cells using a non-directed active site probe , 2010, Proteome Science.

[62]  A. Cunningham,et al.  Analysis of proteins copurifying with the cd4/lck complex using one-dimensional polyacrylamide gel electrophoresis and mass spectrometry: comparison with affinity-tag based protein detection and evaluation of different solubilization methods , 2004, Journal of the American Society for Mass Spectrometry.

[63]  Mike Tyers,et al.  BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..

[64]  C. Fierbinţeanu-Braticevici,et al.  Role of oxidative stress in the pathogenesis of chronic hepatitis C (CHC). , 2009, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[65]  Lingbao Kong,et al.  Hepatitis C virus NS4B induces unfolded protein response and endoplasmic reticulum overload response-dependent NF-kappaB activation. , 2009, Virology.

[66]  M. Mann,et al.  RNA and RNA Binding Proteins Participate in Early Stages of Cell Spreading through Spreading Initiation Centers , 2004, Cell.

[67]  J. Dubuisson,et al.  Role of lipid metabolism in hepatitis C virus assembly and entry , 2010, Biology of the cell.

[68]  Robert Steinbauer,et al.  Site specific phosphorylation of yeast RNA polymerase I , 2007, Nucleic acids research.

[69]  Keiji Tanaka,et al.  Critical role of PA28γ in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis , 2007, Proceedings of the National Academy of Sciences.

[70]  Victoria Wong,et al.  Detecting interactions with membrane proteins using a membrane two-hybrid assay in yeast , 2010, Nature Protocols.

[71]  J. D. del Campo,et al.  Steatosis and insulin resistance in hepatitis C: a way out for the virus? , 2009, World journal of gastroenterology.

[72]  A. Dolganiuc,et al.  Hepatitis C and innate immunity: recent advances. , 2008, Clinics in liver disease.

[73]  R. Sharan,et al.  Protein networks in disease. , 2008, Genome research.

[74]  F. Negro,et al.  Hepatitis C virus and glucose and lipid metabolism. , 2008, Diabetes & metabolism.

[75]  M. Ripoli,et al.  HCV infection induces mitochondrial bioenergetic unbalance: causes and effects. , 2009, Biochimica et biophysica acta.

[76]  R. Bartenschlager,et al.  Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor–induced signal transduction by cleavage of the T‐cell protein tyrosine phosphatase , 2009, Hepatology.

[77]  J. George,et al.  Molecular mechanisms of insulin resistance in chronic hepatitis C. , 2009, World journal of gastroenterology.

[78]  J. Glenn,et al.  Mechanisms of HCV survival in the host , 2009, Nature Reviews Gastroenterology &Hepatology.

[79]  Y. Matsuura,et al.  A Single-Amino-Acid Mutation in Hepatitis C Virus NS5A Disrupting FKBP8 Interaction Impairs Viral Replication , 2008, Journal of Virology.

[80]  M. Ripoli,et al.  Hepatitis C Virus-Linked Mitochondrial Dysfunction Promotes Hypoxia-Inducible Factor 1α-Mediated Glycolytic Adaptation , 2009, Journal of Virology.

[81]  M. Takeda,et al.  Intramembrane Processing by Signal Peptide Peptidase Regulates the Membrane Localization of Hepatitis C Virus Core Protein and Viral Propagation , 2008, Journal of Virology.

[82]  M. Gaca,et al.  Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors. , 2002, Journal of hepatology.

[83]  Lin Deng,et al.  Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells. , 2009, The Journal of general virology.

[84]  Zhidong Yao,et al.  Hepatitis C Virus Core Protein Inhibits Human T Lymphocyte Responses by a Complement-Dependent Regulatory Pathway1 2 , 2001, The Journal of Immunology.

[85]  Fidel Ramírez,et al.  Computing topological parameters of biological networks , 2008, Bioinform..

[86]  Chen-Ming Hsu,et al.  Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activation , 2009, BMC Medical Genomics.

[87]  C. Rice,et al.  Hepatitis C: An unsuspected drug target , 2010, Nature.

[88]  Wu-ling Zhu,et al.  Abnormal expression of fibrinogen gamma (FGG) and plasma level of fibrinogen in patients with hepatocellular carcinoma. , 2009, Anticancer research.

[89]  H. Fukui,et al.  The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation , 2009, Journal of bioenergetics and biomembranes.

[90]  Y. Kuramitsu,et al.  Current progress in proteomic study of hepatitis C virus-related human hepatocellular carcinoma , 2005, Expert review of proteomics.

[91]  J. Mankouri,et al.  The Hepatitis C Virus Non‐Structural Protein NS5A Alters the Trafficking Profile of the Epidermal Growth Factor Receptor , 2008, Traffic.

[92]  Qibin Zhang,et al.  Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics , 2010, PLoS pathogens.

[93]  E. Silberstein,et al.  Innate immunity and hepatitis C virus: eluding the host cell defense. , 2009, Frontiers in bioscience.